Euronext N.V.

Regulatory Filings • Aug 6, 2010

CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for July 2010

Global Derivatives Averaged 7.1 Million Contracts per Day in July, Up 17% vs. Prior Year; European Derivatives ADV Up 11%; U.S. Equity Options ADV Up 27%; European Cash Trading Volumes Increase 20%; U.S. Cash Decreases 7%

August 6, 2010 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for July 20101 . Trading volumes experienced double-digit growth across most venues in July 2010 compared to the prior year period, but declined from June 2010 levels. Global derivatives average daily volume ("ADV") increased 17.5% to 7.1 million contracts traded per day in July 2010. The strong increase in derivatives ADV versus prior year levels was driven by an 11.1% increase in European derivatives ADV and a 26.8% increase in U.S. equity options ADV in July 2010. Cash equities ADV in July 2010 was mixed, with European cash trading volumes increasing 19.5%, but U.S. cash trading volumes decreasing 7.2% compared to prior year levels.

Highlights

• NYSE Euronext global derivatives ADV in July 2010 of 7.1 million contracts increased 17.5% compared to June 2009, but decreased 13.6% from June 2010 levels.
• NYSE Euronext European derivatives products ADV in July 2010 of 4.0 million contracts increased 11.1% compared to July 2009, but decreased 16.4% from June 2010 levels. Total European fixed income products ADV in July 2010 of 2.0 million contracts increased 25.2% compared to July 2009 and increased 4.8% from June 2010. Total equity products ADV of 1.9 million contracts in July 2010 decreased 2.3% compared to July 2009 and decreased 32.0% from June 2010.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.1 million contracts in July 2010 increased 26.8% compared to July 2009 levels, but decreased 9.7% from June 2010. NYSE Euronext's U.S. options exchanges accounted for 25.3% of the total consolidated equity options trading in July 2010, up from 18.8% in July 2009, but down from 26.5% recorded in June 2010.
• NYSE Euronext European cash products ADV of 1.4 million transactions in July 2010 increased 19.5% compared to July 2009, but decreased 9.4% from June 2010.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.6 billion shares in July 2010 decreased 7.2% compared to July 2009 and decreased 12.6% compared to June 2010. NYSE Euronext's Tape A matched market share in July 2010 was 37.6%, up from 36.6% in July 2009, but down from 38.8% in June 2010.
• There were a total of 22 trading days in Europe and 21 in the U.S. in July 2010 compared to 23 days in Europe and 22 days in the U.S. in July 2009.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in June 2010 was 4.0 million futures and options contracts, an increase of 11.1% from July 2009, but a decrease of 16.4% from June 2010. The 4.0 million in futures and options contracts ADV in July 2010 consisted of 3.0 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.9 million contracts, or 23.8%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
• Year-to-date, European derivatives products ADV of 5.5 million contracts was 30.1% above prior year levels. The 5.5 million in futures and options contracts ADV year-to-date consisted of 3.8 million contracts executed through the LIFFE CONNECT trading platform and 1.7 million contracts, or 30.7%, executed through Bclear.
• Total fixed income products ADV of 2.0 million contracts in July 2010 increased 25.2% from July 2009 and increased 4.8% from June 2010. Year-to-date, total fixed income products ADV of 2.6 million contracts was 29.4% above prior year levels.
• Total equity products (including Bclear) ADV of 1.9 million contracts in July 2010 decreased 2.3% compared to July 2009 and decreased 32.0% from June 2010. The 1.9 million contracts in equity products ADV consisted of 1.4 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.3 million contracts in individual equity products ADV consisted of 0.8 million in futures contracts, which represented a 6.6% decrease compared to July 2009, and 0.5 million in options contracts, which represented a 0.3% decrease compared to July 2009. The average rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.8 million contracts was 30.9% above prior year levels.
• Total commodities products ADV of 85,000 contracts in July 2010 increased 88.8% compared to July 2009 and increased 37.2% from June 2010. Year-to-date, total commodities product ADV of 58,000 contracts was 24.2% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.1 million contracts in July 2010 increased 26.8% compared to July 2009, but decreased 9.7% compared to June 2010.
• Year-to-date, U.S. equity options ADV of 3.8 million contracts was 54.9% above prior year levels.
• Total U.S. consolidated equity options ADV decreased 5.8% to 12.2 million contracts in July 2010 compared to July 2009 and decreased 5.6% compared to June 2010. Year-to-date, U.S. consolidated equity options ADV of 14.5 million contracts was 6.5% above prior year levels.
• NYSE Euronext's U.S. options exchanges accounted for 25.3% of the total U.S. consolidated equity options trading in July 2010, up from 18.8% in July 2009, but down from 26.5% in June 2010.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in July 2010 was approximately 11,800 contracts, compared to 16,100 contracts in June 2010. Year-to-date U.S. futures and futures options ADV was 18,500 contracts.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.4 million transactions in July 2010 increased 19.5% compared to July 2009, but decreased 9.4% compared to June 2010.
• Year-to-date, European cash products ADV of 1.5 million transactions was 10.7% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in July 2010 decreased 7.2% to 2.6 billion shares compared to July 2009 and decreased 13.1% from June 2010.
• Year-to-date, U.S. cash products handled ADV was 2.8 billion shares, down 22.6% from prior year levels.
• NYSE Euronext's Tape A matched market share in July 2010 was 37.6%, up from 36.6% in July 2009, but down from 38.8% in June 2010.
• Designated Market Maker participation in July 2010 was 9.6%, compared to 8.5% in June 2010. Supplemental Liquidity Provider participation in July 2010 was 12.4%, compared to 13.3% in June 2010. DMM participation pertains only to trading on NYSE.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 337 million shares in July 2010 decreased 5.2% compared to July 2009 and decreased 11.8% compared to June 2010. Year-to-date, NYSE Euronext U.S. matched exchangetraded products ADV of 367 million shares was 31.3% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2009 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2009 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.